feed,title,long_url,short_url
InsiderMonkey,"Keros Therapeutics, Inc. (KROS) Halts PAH Drug Development After Safety Concerns in TROPOS Trial",https://insidermonkey.com/blog/--1543967,
InsiderMonkey,Lantern Pharma Inc. (LTRN)’s LP-184 Shows 345% Survival Gain in Rare Pediatric Brain Tumor Models,https://insidermonkey.com/blog/--1543974,
InsiderMonkey,"BioAge Labs, Inc. (BIOA)’s BGE-102 Shows Potent Weight Loss, Plans IND Submission Mid-2025",https://insidermonkey.com/blog/--1543979,
InsiderMonkey,"Estrella Immunopharma, Inc. (ESLA) Doses First Patient in Higher-Dose Cohort of EB103 Phase I/II Trial",https://insidermonkey.com/blog/--1543982,
InsiderMonkey,Danaher Corporation (DHR) Launches Partnership with AstraZeneca PLC (AZN) to Scale Next-Gen Precision Medicine Tests,https://insidermonkey.com/blog/--1543929,
InsiderMonkey,"NextCure, Inc. (NXTC) and LCB to Unveil Promising Preclinical Data on B7-H4 ADC at AACR 2024",https://insidermonkey.com/blog/--1543925,
InsiderMonkey,"Bernstein Raises Salesforce (CRM) Price Target to $255, Keeps Underperform Rating",https://insidermonkey.com/blog/--1543508,
InsiderMonkey,"Revelation Biosciences, Inc. (REVB) Raises $4M in Public Offering",https://insidermonkey.com/blog/--1543923,
InsiderMonkey,"Morgan Stanley Lifts Salesforce, Inc. (CRM)’s Price Target to $404, Maintains Overweight Rating",https://insidermonkey.com/blog/--1543912,
InsiderMonkey,Elbit Systems Ltd. (ESLT) Secures $330M in Naval Defense Contracts,https://insidermonkey.com/blog/--1543557,
InsiderMonkey,"Morgan Stanley Raises NVIDIA Corporation (NVDA)’s Stock Price Target to $170, Maintains Overweight Rating",https://insidermonkey.com/blog/--1543324,
